Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elvira Favoino
Observed names:
E Favoino,
E. Favoino,
ELVIRA FAVOINO,
FAVOINO, ELVIRA,
Favoino, Elvira
Institution:
University of Bari Aldo Moro
Observed institutions:
National Institutes of Health,
Harvard University,
University of Pittsburgh,
Massachusetts General Hospital,
UPMC Hillman Cancer Center,
National Cancer Institute,
University of Bari Aldo Moro
show all 7
ORCID:
0000-0002-4664-1394
Observed ORCID:
0000-0002-4664-1394
OpenAlex ID:
A5011670349
Rheumatic disorders as paraneoplastic syndromes
2008
·
Vito Racanelli
, Marcella Prete
, et al.
·
Autoimmunity Reviews
·
173
β2-Microglobulin-Free HLA Class I Heavy Chain Epitope Mimicry by Monoclonal Antibody HC-10-Specific Peptide
2003
·
Federico Perosa
, Grazia Luccarelli
, et al.
·
The Journal of Immunology
·
169
PDF
Endothelial cells in tumor microenvironment: insights and perspectives
2024
·
Patrizia Leone
, Eleonora Malerba
, et al.
·
Frontiers in Immunology
·
167
PDF
CSPG4 in Cancer: Multiple Roles
2010
·
X. Wang
, Y. Wang
, et al.
·
Current Molecular Medicine
·
135
Raynaud's phenomenon: From molecular pathogenesis to therapy
2014
·
Marcella Prete
, Maria Celeste Fatone
, et al.
·
Autoimmunity Reviews
·
134
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor
2005
·
Federico Perosa
, Elvira Favoino
, et al.
·
Blood
·
113
PDF
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment
2020
·
Marcella Prete
, Elvira Favoino
, et al.
·
International Journal of Molecular Sciences
·
89
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders
2018
·
Claudia Floriana Suciu
, Marcella Prete
, et al.
·
Autoimmunity Reviews
·
88
CD20: A target antigen for immunotherapy of autoimmune diseases
2005
·
Federico Perosa
, Elvira Favoino
, et al.
·
Autoimmunity Reviews
·
85
Functional Characterization of an scFv-Fc Antibody that Immunotherapeutically Targets the Common Cancer Cell Surface Proteoglycan CSPG4
2011
·
Xinhui Wang
, Akihiro Katayama
, et al.
·
Cancer Research
·
67
PDF
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
2021
·
Elvira Favoino
, Marcella Prete
, et al.
·
Autoimmunity Reviews
·
62
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma
2015
·
F Sabbatino
, E Favoino
, et al.
·
Journal of Translational Medicine
·
49
PDF
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
2016
·
Francesco Sabbatino
, Yangyang Wang
, et al.
·
JNCI Journal of the National Cancer Institute
·
45
PDF
The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells
2011
·
Ling Yu
, Elvira Favoino
, et al.
·
Immunologic Research
·
41
HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors
2015
·
Rosa Sottile
, Pradeepa N. Pangigadde
, et al.
·
European Journal of Immunology
·
40
PDF
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin
2015
·
Federico Perosa
, Marcella Prete
, et al.
·
Autoimmunity Reviews
·
33
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
2020
·
Marcella Prete
, Elvira Favoino
, et al.
·
Autoimmunity Reviews
·
31
PDF
Two Structurally Different Rituximab-Specific CD20 Mimotope Peptides Reveal That Rituximab Recognizes Two Different CD20-Associated Epitopes
2009
·
Federico Perosa
, Elvira Favoino
, et al.
·
The Journal of Immunology
·
30
Identification of an Antigenic and Immunogenic Motif Expressed by Two 7-Mer Rituximab-Specific Cyclic Peptide Mimotopes: Implication for Peptide-Based Active Immunotherapy
2007
·
Federico Perosa
, Elvira Favoino
, et al.
·
The Journal of Immunology
·
23
PDF
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease
2016
·
Federico Perosa
, Elvira Favoino
, et al.
·
Medicine
·
19
CD20 Mimicry by a mAb Rituximab-Specific Linear Peptide: A Potential Tool for Active Immunotherapy of Autoimmune Diseases
2005
·
FEDERICO PEROSA
, ELVIRA FAVOINO
, et al.
·
Annals of the New York Academy of Sciences
·
19
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)
2024
·
Vasiliki Liakouli
, Ignazio Verde
, et al.
·
Clinical and Experimental Rheumatology
·
17
PDF
Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice
2013
·
E Favoino
, E I Favia
, et al.
·
Clinical & Experimental Immunology
·
16
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity
2024
·
Elvira Favoino
, Marcella Prete
, et al.
·
Autoimmunity Reviews
·
15
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease
2005
·
M. Prete
, F. Perosa
, et al.
·
Clinical and Experimental Medicine
·
15
Show more works
View as search
Works count:
104
Citation count:
1,848
H-index:
19
I10-index:
33
Year
Topic
Type